DK1140873T3 - IL-5-inhiberende 6-azauracilderivater - Google Patents

IL-5-inhiberende 6-azauracilderivater

Info

Publication number
DK1140873T3
DK1140873T3 DK99965509T DK99965509T DK1140873T3 DK 1140873 T3 DK1140873 T3 DK 1140873T3 DK 99965509 T DK99965509 T DK 99965509T DK 99965509 T DK99965509 T DK 99965509T DK 1140873 T3 DK1140873 T3 DK 1140873T3
Authority
DK
Denmark
Prior art keywords
inhibiting
azauracil derivatives
azauracil
derivatives
Prior art date
Application number
DK99965509T
Other languages
English (en)
Inventor
Eddy Jean Edgard Freyne
Frederik Dirk Deroose
Jean Fernand Armand J Lacrampe
Werner Constant Joha Embrechts
Jerome Michel Claude Ja Fortin
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1140873T3 publication Critical patent/DK1140873T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99965509T 1998-12-18 1999-12-16 IL-5-inhiberende 6-azauracilderivater DK1140873T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204336 1998-12-18
PCT/EP1999/010169 WO2000037451A1 (en) 1998-12-18 1999-12-16 Il-5 inhibiting 6-azauracil derivatives

Publications (1)

Publication Number Publication Date
DK1140873T3 true DK1140873T3 (da) 2007-10-15

Family

ID=8234494

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99965509T DK1140873T3 (da) 1998-12-18 1999-12-16 IL-5-inhiberende 6-azauracilderivater

Country Status (35)

Country Link
US (1) US6803364B1 (da)
EP (1) EP1140873B1 (da)
JP (1) JP2002533331A (da)
KR (1) KR100635721B1 (da)
CN (1) CN100343239C (da)
AR (1) AR021887A1 (da)
AT (1) ATE365723T1 (da)
AU (1) AU773780B2 (da)
BG (1) BG105602A (da)
BR (1) BR9916366A (da)
CA (1) CA2354511A1 (da)
CO (1) CO5150147A1 (da)
CZ (1) CZ20012062A3 (da)
DE (1) DE69936396T2 (da)
DK (1) DK1140873T3 (da)
EA (1) EA004806B1 (da)
EE (1) EE200100320A (da)
ES (1) ES2289835T3 (da)
HK (1) HK1042491A1 (da)
HR (1) HRP20010455A2 (da)
HU (1) HUP0104641A3 (da)
ID (1) ID28880A (da)
IL (1) IL143766A (da)
MY (1) MY125808A (da)
NO (1) NO319814B1 (da)
NZ (1) NZ512748A (da)
PL (1) PL198205B1 (da)
PT (1) PT1140873E (da)
SA (1) SA00201030B1 (da)
SK (1) SK8152001A3 (da)
TR (1) TR200101729T2 (da)
TW (1) TWI249530B (da)
UA (1) UA73107C2 (da)
WO (1) WO2000037451A1 (da)
ZA (1) ZA200104942B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466096B2 (en) * 2007-04-26 2013-06-18 Afton Chemical Corporation 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
RU2523651C2 (ru) * 2012-05-22 2014-07-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Владивостокский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО ВГМУ Минздравсоцразвития России) Способ дифференцированного контроля базисного противовоспалительного лечения бронхиальной астмы у детей и подростков
RU2506045C1 (ru) * 2012-09-05 2014-02-10 Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" Сибирского отделения РАМН Способ прогнозирования достижения контроля бронхиальной астмы
CN119161311B (zh) * 2024-11-20 2025-02-11 北京纳百生物科技有限公司 一种地克珠利抗原及其合成方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2149645A1 (de) 1970-10-07 1972-09-14 Pfizer 2-Phenyl-as-triazin-3.5-(2H,4H)-dione und die Verwendung dieser Verbindungen zur Bekaempfung der Coccidiose
US3912723A (en) 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
US3883528A (en) 1974-04-19 1975-05-13 Pfizer Preparation of 2(aryl)-as-triazine-3,5(2H,4H)-dione coccidiostats
CA1244024A (en) 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
US4631278A (en) 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
CA1331757C (en) 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
EP0476439A1 (de) 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
TW263495B (da) 1992-12-23 1995-11-21 Celltech Ltd
GB9304920D0 (en) 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
TW403741B (en) 1993-10-15 2000-09-01 Takeda Chemical Industries Ltd Triazine derivative, production and use thereof
TW332201B (en) 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
DE69615601T2 (de) 1995-04-14 2002-07-11 Takeda Schering-Plough Animal Health K.K., Osaka Verfahren zur Herstellung von Triazinderivate
EP0831088B1 (en) * 1996-08-30 2002-11-27 Takeda Schering-Plough Animal Health K.K. 1,2,4-Triazine-3,5-dione derivatives as anticoccidial agents
CN1261881A (zh) * 1997-07-10 2000-08-02 詹森药业有限公司 作为il-5-抑制剂的6-氮杂尿嘧啶衍生物
HRP20000003A2 (en) * 1997-07-10 2000-12-31 Janssen Pharmaceutica Nv Il-5 inhibiting 6-azauracil derivatives

Also Published As

Publication number Publication date
JP2002533331A (ja) 2002-10-08
EA200100677A1 (ru) 2001-12-24
DE69936396T2 (de) 2008-06-19
TR200101729T2 (tr) 2001-10-22
AU773780B2 (en) 2004-06-03
NO20012987D0 (no) 2001-06-15
HK1042491A1 (zh) 2002-08-16
NZ512748A (en) 2004-05-28
US6803364B1 (en) 2004-10-12
PL198205B1 (pl) 2008-06-30
CN100343239C (zh) 2007-10-17
CA2354511A1 (en) 2000-06-29
SA00201030B1 (ar) 2006-10-11
WO2000037451A1 (en) 2000-06-29
AU2100100A (en) 2000-07-12
BG105602A (en) 2002-01-31
EP1140873A1 (en) 2001-10-10
ATE365723T1 (de) 2007-07-15
CZ20012062A3 (cs) 2002-03-13
KR20010080617A (ko) 2001-08-22
CO5150147A1 (es) 2002-04-29
EE200100320A (et) 2002-10-15
UA73107C2 (en) 2005-06-15
ZA200104942B (en) 2002-06-18
SK8152001A3 (en) 2002-04-04
KR100635721B1 (ko) 2006-10-17
IL143766A0 (en) 2002-04-21
NO20012987L (no) 2001-08-17
AR021887A1 (es) 2002-08-07
HUP0104641A3 (en) 2003-01-28
ID28880A (id) 2001-07-12
MY125808A (en) 2006-08-30
HRP20010455A2 (en) 2002-06-30
EA004806B1 (ru) 2004-08-26
EP1140873B1 (en) 2007-06-27
TWI249530B (en) 2006-02-21
NO319814B1 (no) 2005-09-19
CN1330643A (zh) 2002-01-09
IL143766A (en) 2005-11-20
ES2289835T3 (es) 2008-02-01
HUP0104641A2 (hu) 2002-04-29
PT1140873E (pt) 2007-10-10
BR9916366A (pt) 2001-09-18
DE69936396D1 (de) 2007-08-09

Similar Documents

Publication Publication Date Title
NO20010193D0 (no) Tiobenzimidazol-derivater
DK0930302T3 (da) Benzosulfonderivater
DE69934788D1 (de) Biozide benzylbiphenylderivative
NO20010514L (no) Aminometylkarboksylsyre-derivater
ATE259810T1 (de) Phenyl-xanthinderivate
ATE277941T1 (de) Adenosinderivate
PT928790E (pt) Derivados de tiazolo
ATE364597T1 (de) Il-5 hemmende 6-azauracilderivate
PL353475A1 (pl) Pochodne 6-azauracylu hamujące interleukinę-5
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
PT1056716E (pt) Derivados de ciclo-hexanodiolo
ATE233253T1 (de) Chromanderivate
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
DK1060183T3 (da) 5-deoxycytidinderivater
PT1123283E (pt) Derivados de tiazole
DK1140873T3 (da) IL-5-inhiberende 6-azauracilderivater
ATE238301T1 (de) Interleukin-5 hemmende 6-azauracil derivate
DE69907254D1 (de) 6-azauracilderivate als il-5 inhibitoren
IL133915A0 (en) 6-azauracil derivatives as il-5 inhibitors
PT928793E (pt) Derivados de tiazol
ATE289596T1 (de) Il-5 hemmende 6-azauracilderivate
DE59907635D1 (de) Pyrazolyldioxothiochromanoyl-derivate